BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17089790)

  • 1. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery.
    Holland TA; Mikos AG
    Adv Biochem Eng Biotechnol; 2006; 102():161-85. PubMed ID: 17089790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymers as biomaterials for tissue engineering and controlled drug delivery.
    Nair LS; Laurencin CT
    Adv Biochem Eng Biotechnol; 2006; 102():47-90. PubMed ID: 17089786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A poly(glycerol sebacate)-coated mesoporous bioactive glass scaffold with adjustable mechanical strength, degradation rate, controlled-release and cell behavior for bone tissue engineering.
    Lin D; Yang K; Tang W; Liu Y; Yuan Y; Liu C
    Colloids Surf B Biointerfaces; 2015 Jul; 131():1-11. PubMed ID: 25935647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-printed dimethyloxallyl glycine delivery scaffolds to improve angiogenesis and osteogenesis.
    Min Z; Shichang Z; Chen X; Yufang Z; Changqing Z
    Biomater Sci; 2015 Aug; 3(8):1236-44. PubMed ID: 26222039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric scaffolds for bone tissue engineering.
    Liu X; Ma PX
    Ann Biomed Eng; 2004 Mar; 32(3):477-86. PubMed ID: 15095822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porosity of 3D biomaterial scaffolds and osteogenesis.
    Karageorgiou V; Kaplan D
    Biomaterials; 2005 Sep; 26(27):5474-91. PubMed ID: 15860204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds.
    Kanczler JM; Mirmalek-Sani SH; Hanley NA; Ivanov AL; Barry JJ; Upton C; Shakesheff KM; Howdle SM; Antonov EN; Bagratashvili VN; Popov VK; Oreffo RO
    Acta Biomater; 2009 Jul; 5(6):2063-71. PubMed ID: 19362063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.
    Oliveira JM; Rodrigues MT; Silva SS; Malafaya PB; Gomes ME; Viegas CA; Dias IR; Azevedo JT; Mano JF; Reis RL
    Biomaterials; 2006 Dec; 27(36):6123-37. PubMed ID: 16945410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
    Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
    Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcellular polyHIPE polymer supports osteoblast growth and bone formation in vitro.
    Akay G; Birch MA; Bokhari MA
    Biomaterials; 2004 Aug; 25(18):3991-4000. PubMed ID: 15046889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro.
    Lu HH; El-Amin SF; Scott KD; Laurencin CT
    J Biomed Mater Res A; 2003 Mar; 64(3):465-74. PubMed ID: 12579560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.
    Mouriño V; Cattalini JP; Roether JA; Dubey P; Roy I; Boccaccini AR
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1353-65. PubMed ID: 23777443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated adipose-derived stem cell cocultures for bone regeneration in polymer scaffolds in vivo.
    Shah AR; Cornejo A; Guda T; Sahar DE; Stephenson SM; Chang S; Krishnegowda NK; Sharma R; Wang HT
    J Craniofac Surg; 2014 Jul; 25(4):1504-9. PubMed ID: 24943502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocomposite scaffolds with tunable mechanical and degradation capabilities: co-delivery of bioactive agents for bone tissue engineering.
    Cattalini JP; Roether J; Hoppe A; Pishbin F; Haro Durand L; Gorustovich A; Boccaccini AR; Lucangioli S; Mouriño V
    Biomed Mater; 2016 Oct; 11(6):065003. PubMed ID: 27767020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro ossification and remodeling of mineralized collagen I scaffolds.
    Domaschke H; Gelinsky M; Burmeister B; Fleig R; Hanke T; Reinstorf A; Pompe W; Rösen-Wolff A
    Tissue Eng; 2006 Apr; 12(4):949-58. PubMed ID: 16674306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
    Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
    Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects.
    Oest ME; Dupont KM; Kong HJ; Mooney DJ; Guldberg RE
    J Orthop Res; 2007 Jul; 25(7):941-50. PubMed ID: 17415756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable poly(alpha-hydroxy acid) polymer scaffolds for bone tissue engineering.
    Yu NY; Schindeler A; Little DG; Ruys AJ
    J Biomed Mater Res B Appl Biomater; 2010 Apr; 93(1):285-95. PubMed ID: 20127987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering craniofacial scaffolds.
    Hollister SJ; Lin CY; Saito E; Lin CY; Schek RD; Taboas JM; Williams JM; Partee B; Flanagan CL; Diggs A; Wilke EN; Van Lenthe GH; Müller R; Wirtz T; Das S; Feinberg SE; Krebsbach PH
    Orthod Craniofac Res; 2005 Aug; 8(3):162-73. PubMed ID: 16022718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Polymer-Cell Bioconstructs for Bone Tissue Engineering.
    Titorencu I; Albu MG; Nemecz M; Jinga VV
    Curr Stem Cell Res Ther; 2017; 12(2):165-174. PubMed ID: 26521973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.